PRESCIENT: platform for the rapid evaluation of antibody success using integrated microfluidics enabled technology
Identifying antibodies (Abs) that neutralize infectious agents is the first step for developing therapeutics, vaccines, and diagnostic tools for these infectious agents.
1985 ◽
Vol 310
(1144)
◽
pp. 259-274
◽
Keyword(s):
1971 ◽
Vol 29
◽
pp. 304-305
2014 ◽
Vol 23
(2)
◽
pp. 91-98
◽
2008 ◽
Vol 2008
◽
pp. 130-131